JP
Jacobio Pharmaceuticals develops first-in-class therapeutics targeting difficult-to-drug oncology pathways, utilizing its proprietary drug discovery platforms, including iADC and induced-fit technology. The company focuses on addressing the unmet medical needs in cancer treatment through innovative combination therapies and has multiple projects in advanced clinical stages.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Jacobio Pharmaceuticals develops first-in-class therapeutics targeting difficult-to-drug oncology pathways, utilizing its proprietary drug discovery platforms, including iADC and induced-fit technology. The company focuses on addressing the unmet medical needs in cancer treatment through innovative combination therapies and has multiple projects in advanced clinical stages.